(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






644 Result: Form 10-K

American Video Teleconferencing Corp. Announces Changes to its Board of Directors and Principal Officers

May 10th, 2019

LAS VEGAS, NV / CRWE PRESS RELEASE / May 10, 2019  -  American Video Teleconferencing Corp. (AVOT) today announced the resignation of its Chairman and CEO, Kevin Wiltz effective immediately. American Video Teleconferencing Corp. would li. Read more

Crown Equity Holdings Inc. Announces Board and Officer Resignations

May 10th, 2019

LAS VEGAS, NV / CRWE PRESS RELEASE / May 10, 2019  - Crown Equity Holdings Inc. (OTC PINK: CRWE) today announces the resignation of its Director and Vice President, Brian D. Colvin and Director and Chief Operating Officer, Arnulfo Saucedo-Bardan. Read more

Crown Equity Holdings Inc. Announces Changes To Its Board Of Directors And Principal Officers

January 09th, 2019

LAS VEGAS, NV / CRWE PRESS RELEASE  / January 9, 2019 - Crown Equity Holdings Inc. (OTC PINK: CRWE) today announced the resignation of Steven A. Cantor as its Chairman of the Board, and Deborah Robinson as one of its directors, and Chief Marketi. Read more

American Video Teleconferencing Corp. Announces Changes to its Board of Directors and Principal Officers

December 17th, 2018

LAS VEGAS, NV / CRWE PRESS RELEASE / December 17, 2018 - American Video Teleconferencing Corp. (PINK SHEETS: AVOT) today announced the resignation of its: CEO/President and Chairman, Mike Zaman,  Chief Financial Officer and Director, Kenneth Bos. Read more

Crown Equity Holdings, Inc., a Vertically Integrated, Global Media and Financial Services Company Announces Fully Reporting Update and New Fashion Industry Client

July 05th, 2018

LAS VEGAS, NV / CRWE PRESS RELEASE / July 5, 2018 /Crown Equity Holdings, Inc. (OTC PINK: CRWE), a vertically integrated global media and financial services company is proud to announce that it is in preparation of launching its global platform durin. Read more

Crown Equity Holdings Inc., a Vertically Integrated Global Media and Financial Services Company, Announces New Chairman of the Board

June 27th, 2018

Las Vegas, NV / CRWE PRESS RELEASE / June 27, 2018 / Crown Equity Holdings Inc. (OTC PINK: CRWE) is pleased to announce today that Steven A. Cantor has been elected by its Board to serve as Chairman of its Board of Directors. Mr. Cantor will succe. Read more

Crown Equity Holdings, Inc. Engages Attorney Arnold F. Sock as Securities Counsel

May 01st, 2018

LAS VEGAS, NV / CRWE PRESS RELEASE / April 30, 2018 - Crown Equity Holdings, Inc. (Pink Sheets: CRWE) announced today that the company has engaged Attorney Arnold F. Sock as securities counsel. Mr. Sock has extensive senior level management abilities. Read more

American Video Teleconferencing Corp. Engages Attorney Arnold F. Sock as Securities Counsel

April 30th, 2018

LAS VEGAS, NV / CRWE PRESS RELEASE / April 30, 2018 - American Video Teleconferencing Corp. (Pink Sheets: AVOT) announced today that the company has engaged Attorney Arnold F. Sock as securities counsel. Mr. Sock has extensive senior level management. Read more

Puma Biotechnology Announces European Medicines Agency Validation of Marketing Authorization Application for PB272 (Neratinib) as Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer in Europe

August 22nd, 2016

LOS ANGELES, Calif. / CRWE PRESS RELEASE / August 22, 2016 - Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that the Marketing Authorization Application (MAA) for neratinib has been validated by the European Medicines A. Read more

Cesca Therapeutics Announces Promising Results From 40-Month Follow-Up of Patients Enrolled in Critical Limb Ischemia Feasibility Study

August 03rd, 2016

Rancho Cordova, Calif. / CRWE PRESS RELEASE / August 03, 2016 - Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced 40-month follow-up results for a number of patients that particip. Read more

EyeGate Announces Positive Top-line Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Post-Operative Inflammation and Pain in Cataract Surgery Patients

August 01st, 2016

WALTHAM, Mass. / CRWE PRESS RELEASE / Aug. 01, 2016 — EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing produ. Read more

Shire Recommends ADS Holders Reject TRC Capital's "Mini-Tender Offer"

July 29th, 2016

Dublin, Ireland / CRWE PRESS RELEASE / July 29, 2016 – Shire plc (LSE: SHP) (NASDAQ: SHPG) has been notified of an unsolicited “mini-tender” offer made by TRC Capital Corporation (“TRC Capital”) to purchase up to 1,000,0. Read more

Anavex Presents 31-Week Efficacy Data from Phase 2a Study of ANAVEX 2-73 in Alzheimer's Patients at AAIC 2016

July 27th, 2016

Sustained Response Through 31 Weeks for both Cognitive (MMSE) and Functional (ADCS-ADL) Measures NEW YORK, NY / CRWE PRESS RELEASE / July 27, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL. Read more

Verizon to acquire Yahoo's operating business

July 25th, 2016

Transaction will create a new rival in mobile media technology reaching over 1B users* with an unrivaled roster of the world’s most beloved brands BASKING RIDGE, NJ, and SUNNYVALE, Calif. / CRWE PRESS RELEASE / July 25, 2016 &ndash. Read more

ONIVYDE(R) Receives Positive CHMP Opinion for Treatment of Patients with Metastatic Adenocarcinoma of the Pancreas who have Progressed Following Gemcitabine based Therapy

July 25th, 2016

The positive opinion is based on a pivotal Phase 3 study showing that ONIVYDE combined with chemotherapy significantly increased overall survival (OS) in patients with metastatic pancreatic cancer after previous gemcitabine based therapy Zug, Swit. Read more

Load More Content